PACIFIC: A Double-blind, Placebo-controlled Phase III Study of Durvalumab as Consolidation Therapy after Chemoradiation in Patients with Locally Advanced, Unresectable NSCLC

"The ADscopal Effect? Control of Partially Irradiated versus Completely Irradiated Tumors on a Prospective Trial of Pembrolizumab and SBRT per NRG-BR001 "

"Clinical outcomes of metastatic lung cancer patients treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy "

"Phase I/II Trial of Ipilimumab (Immunotherapy) and Hypofractionated Stereotactic Radiation Therapy in Patients with Advanced Solid Malignancies "

"Consolidative Radiotherapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial "

SBRT for central tumors in early stage NSCLC patients

"Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer "

"HELPER Study：A Phase II Trial of Continuous Infusion of Recombinant Human Endostatin (Endostar) Combined with Concurrent Etoposide plus Cisplatin and Radiotherapy for Treatment of Unresectable Stage III NSCLC "

"Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose (60 Gy) versus High Dose (74 Gy) Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC "

"Health related quality of life (HRQoL) outcomes in a phase III randomized trial of optimization of treatment of advanced non small cell lung cancer using radiotherapy and chemotherapy: IAEA multicentric study (NCT00864331) "

"PET-Adjusted Intensity-Modulated Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Prospective Trial (PAINT) "

The international atomic energy agency randomized trial on chemotherapy with or without radiotherapy in advanced NSCLC (NCT00864331)

"Heart Dosimetric Analysis of Three Types of Cardiac Toxicity in Patients Treated on Dose-Escalation Trials for Stage III Non-Small-Cell Lung Cancer "

The NEAT Predictive Model for Survival in Patients with Advanced Cancer

病例讨论